Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin trough concentration

被引：3
|
作者：
Sazanami, Kohei [1 ,2 ]
Inose, Ryo [2 ]
Dote, Satoshi [1 ]
Horiuchi, Nozomu [1 ]
Kobayashi, Yuka [1 ]
Muraki, Yuichi [2 ]
机构：
[1] Kyoto Katsura Hosp, Dept Pharm, Kyoto, Japan
[2] Kyoto Pharmaceut Univ, Dept Clin Pharmacoepidemiol, Kyoto, Japan
来源：
JOURNAL OF CHEMOTHERAPY | 2021年 / 33卷 / 06期
关键词：
D O I：
10.1080/1120009X.2020.1848298
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Incidence of acute kidney injury among patients receiving the combination of vancomycin with piperacillin-tazobactam or meropenem
    Robertson, Amy
    Li, Chenghui
    Hammond, Drayton
    Dickey, Tiffany
    PHARMACOTHERAPY, 2017, 37 (12): : E183 - E184
  • [22] Incidence of Acute Kidney Injury among Patients Treated with Piperacillin-Tazobactam or Meropenem in Combination with Vancomycin
    Rutter, W. Cliff
    Burgess, David S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (07)
  • [23] Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem
    Robertson, Amy D.
    Li, Chenghui
    Hammond, Drayton A.
    Dickey, Tiffany A.
    PHARMACOTHERAPY, 2018, 38 (12): : 1184 - 1193
  • [24] Risk of Acute Kidney Injury in Patients Treated with Vancomycin and Piperacillin/Tazobactam Compared to Vancomycin and Meropenem or Doripenem: A Retrospective Cohort Study
    Ide, Naohito
    Sato, Seitaro
    Sawaguchi, Kazuyo
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2019, 139 (12): : 1609 - 1614
  • [25] An example of robust Pharmacovigilance practice: a safety signal of acute kidney injury with combination therapy of piperacillin/tazobactam and vancomycin
    Harmeyer, S.
    Hewlett, D.
    Delgado, M.
    Wang, W.
    Younus, M.
    Reich, L.
    DRUG SAFETY, 2017, 40 (10) : 961 - 961
  • [26] Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime
    Clemmons, Amber B.
    Bech, Christine F.
    Pantin, Jeremy
    Ahmad, Imran
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 820 - 826
  • [27] Concomitant vancomycin and piperacillin/tazobactam treatment is associated with an increased risk of acute kidney injury in Japanese patients
    Haruki, Yuto
    Hagiya, Hideharu
    Haruki, Mai
    Inoue, Yuta
    Sugiyama, Tetsuhiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (10) : 1026 - 1032
  • [28] Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin-Tazobactam or Cefepime
    Gomes, Diane M.
    Smotherman, Carmen
    Birch, Amy
    Dupree, Lori
    Della Vecchia, Bethany J.
    Kraemer, Dale F.
    Jankowski, Christopher A.
    PHARMACOTHERAPY, 2014, 34 (07): : 662 - 669
  • [29] The Effect of Vancomycin and Piperacillin-Tazobactam on Incidence of Acute Kidney Injury in Patients With Obesity
    Wuerger, Angela
    Bowden, Jarred
    Mitchell, Anna
    Marler, Jacob
    HOSPITAL PHARMACY, 2023, 58 (06) : 605 - 613
  • [30] Risk of acute kidney injury in critically-Ill patients receiving concomitant vancomycin and piperacillin-tazobactam compared to vancomycin and cefepime
    Molina, Kyle
    Yazdani, Cyrus
    Barletta, Jeffrey
    Hall, Scott
    Huang, Vanthida
    PHARMACOTHERAPY, 2017, 37 (12): : E150 - E150
12345